# Ondansetron

NDC: 0121-4882
Generic name: Ondansetron
Labeler / Manufacturer: PAI Holdings, LLC dba PAI Pharma
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20260609

FDA application: ANDA078127

## Active ingredients

- ONDANSETRON HYDROCHLORIDE: 4 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0121-4882"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0121-4882
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68a4d845-0c1c-4867-bfca-c0fb11dc93cd